Skip to main navigation
Skip to content
Aerpio Pharmaceuticals
  • Home
  • About Us
    • The Company
    • Leadership
    • Clinical Advisors
    • Board
    • Careers
  • Our Science
    • The mTOR Pathway
    • The Product
    • Publications and Abstracts
  • Pipeline
    • Pipeline Clinical Studies
    • Advanced PEComa
    • TSC1 and TSC2 Inactivating Alterations
  • Expanded Access
  • Contact
Aerpio Pharmaceuticals

Breadcrumb

  • Home >>
  • Investors >>
  • sec filings >>
  • 0001209191 22 037893 >>

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
06/17/22
Document Date
06/17/22
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Aadi Bioscience, Inc.
Issuer
AADI BIOSCIENCE, INC.
Filer
Reeve Emma

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • IR Contacts

Investor Relations

  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Press Releases
  • Event Calendar
  • Corporate Presentations
  • Scientific Presentations
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
    • Forms
  • Corporate Governance
    • Governance Highlights
    • Committee Composition
  • Investor Resources
    • Investor FAQ
    • Information Request
    • E-mail Alerts
    • IR Contacts
  • Home
  • Leadership
  • Pipeline
  • Contact
  • Careers